Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin

CL Haass-Koffler, K Goodyear, WH Zywiak… - Drug and alcohol …, 2017 - Elsevier
Background Preclinical and clinical research suggest that the α 1 receptor antagonist
prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role for …

Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.

CL Haass-Koffler, K Goodyear, WH Zywiak… - Drug and Alcohol …, 2017 - europepmc.org
Background Preclinical and clinical research suggest that the α 1 receptor antagonist
prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role for …

Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin

CL Haass-Koffler, K Goodyear, WH Zywiak, M Magill… - 2017 - pubmed.ncbi.nlm.nih.gov
Background Preclinical and clinical research suggest that the α 1 receptor antagonist
prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role for …

[HTML][HTML] Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin

CL Haass-Koffler, K Goodyear, WH Zywiak… - Drug and alcohol …, 2017 - ncbi.nlm.nih.gov
Background Preclinical and clinical research suggest that the α1 receptor antagonist
prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role of …

Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.

CL Haass-Koffler, K Goodyear, WH Zywiak… - Drug and Alcohol …, 2017 - psycnet.apa.org
Background: Preclinical and clinical research suggest that the α1 receptor antagonist
prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role for …

Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.

CL Haass-Koffler, K Goodyear, WH Zywiak… - Drug and Alcohol …, 2017 - europepmc.org
Background Preclinical and clinical research suggest that the α 1 receptor antagonist
prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role for …